Clinical Trial Update: Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the intraocular pressure lowering effect of Xalacom in patients with primary open-angle glaucoma or ocular hypertension; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Xalacom (latanoprost/timolol)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED